PubRank

Huib N Caron

Author PubWeight™ 114.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003 11.27
2 Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 2008 5.86
3 Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 2007 5.74
4 Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 2012 4.53
5 Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. Eur J Cancer 2006 2.99
6 LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nat Genet 2012 1.96
7 Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. Arch Intern Med 2010 1.87
8 High incidence of malformation syndromes in a series of 1,073 children with cancer. Am J Med Genet A 2005 1.85
9 Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells. Proc Natl Acad Sci U S A 2009 1.66
10 Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol 2011 1.62
11 Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers. Clin Chem 2009 1.62
12 High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol 2012 1.53
13 Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Res 2008 1.50
14 A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer 2012 1.49
15 Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane Database Syst Rev 2011 1.31
16 Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy. Cochrane Database Syst Rev 2009 1.28
17 Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer 2006 1.22
18 Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma. Genes Chromosomes Cancer 2003 1.21
19 Different anthracycline derivates for reducing cardiotoxicity in cancer patients. Cochrane Database Syst Rev 2010 1.20
20 Prevalence and patterns of morphological abnormalities in patients with childhood cancer. JAMA 2008 1.18
21 Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age. Eur J Cancer 2008 1.18
22 Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma. Eur J Cancer 2007 1.15
23 High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type. Int J Cancer 2003 1.11
24 A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients. Mol Cancer 2010 1.10
25 Prevalence of rib anomalies in normal Caucasian children and childhood cancer patients. Eur J Med Genet 2005 1.09
26 Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma. Cell Mol Life Sci 2009 1.09
27 Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancer. Thorax 2011 1.08
28 Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors. Clin Cancer Res 2003 1.08
29 Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review. Cancer Treat Rev 2009 1.05
30 PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma. J Clin Oncol 2008 1.05
31 Anthracycline cardiotoxicity in children. N Engl J Med 2004 1.01
32 Longitudinal assessment of health-related quality of life in preschool children with non-CNS cancer after the end of successful treatment. Pediatr Blood Cancer 2008 0.97
33 Copy number defects of G1-cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis. Genes Chromosomes Cancer 2011 0.96
34 Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe. Endocr Relat Cancer 2011 0.95
35 High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. Cochrane Database Syst Rev 2013 0.95
36 Gene expression profiling in response to the histone deacetylase inhibitor BL1521 in neuroblastoma. Exp Cell Res 2005 0.94
37 Different anthracycline derivates for reducing cardiotoxicity in cancer patients. Cochrane Database Syst Rev 2010 0.93
38 Histone deacetylase inhibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins. FEBS Lett 2005 0.92
39 Nutritional status at admission of children with cancer in Malawi. Pediatr Blood Cancer 2008 0.90
40 Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression. Eur J Cancer 2011 0.90
41 Mannose-binding lectin (MBL) substitution: recovery of opsonic function in vivo lags behind MBL serum levels. J Immunol 2009 0.89
42 Prevalence of congenital heart defects in neuroblastoma patients: a cohort study and systematic review of literature. Eur J Pediatr 2008 0.89
43 Evaluation of late adverse events in long-term wilms' tumor survivors. Int J Radiat Oncol Biol Phys 2010 0.88
44 The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene 2002 0.88
45 Should anthracyclines and dexrazoxane be used for children with cancer? Lancet Oncol 2011 0.87
46 Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. Cochrane Database Syst Rev 2011 0.87
47 Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors. Eur J Cancer 2012 0.87
48 Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines. Eur J Cancer 2006 0.87
49 Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials. Eur J Cancer 2006 0.87
50 Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi. Pediatr Blood Cancer 2009 0.87
51 The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cells. Biochem Pharmacol 2004 0.86
52 High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. Cochrane Database Syst Rev 2010 0.86
53 Identification of BIRC6 as a novel intervention target for neuroblastoma therapy. BMC Cancer 2012 0.86
54 Psychosocial indicators of health-related quality of life in children with cancer 2 months after end of successful treatment. J Pediatr Hematol Oncol 2007 0.86
55 Coping and family functioning predict longitudinal psychological adaptation of siblings of childhood cancer patients. J Pediatr Psychol 2004 0.86
56 Acute malnutrition is common in Malawian patients with a Wilms tumour: A role for peanut butter. Pediatr Blood Cancer 2009 0.86
57 Cyclopentenyl cytosine-induced activation of deoxycytidine kinase increases gemcitabine anabolism and cytotoxicity in neuroblastoma. Cancer Chemother Pharmacol 2005 0.85
58 Dose-effect relationships for adverse events after cranial radiation therapy in long-term childhood cancer survivors. Int J Radiat Oncol Biol Phys 2012 0.85
59 Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal study. Cancer Epidemiol Biomarkers Prev 2013 0.84
60 Course of life of survivors of childhood cancer is related to quality of life in young adulthood. J Psychosoc Oncol 2007 0.84
61 Health-related quality of life in children and emotional reactions of parents following completion of cancer treatment. Pediatr Blood Cancer 2006 0.84
62 Stability of PCR targets for monitoring minimal residual disease in neuroblastoma. J Mol Diagn 2012 0.83
63 Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaenia. Eur J Cancer 2008 0.83
64 Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children. Cochrane Database Syst Rev 2010 0.83
65 Malnourished Malawian patients presenting with large Wilms tumours have a decreased vincristine clearance rate. Eur J Cancer 2010 0.83
66 Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth. Eur J Cancer 2012 0.83
67 Evaluation of a patient information website for childhood cancer survivors. Support Care Cancer 2012 0.83
68 Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer. Cochrane Database Syst Rev 2011 0.83
69 MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis. Eur J Nucl Med Mol Imaging 2014 0.83
70 Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children. Cochrane Database Syst Rev 2012 0.82
71 Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cells. Haematologica 2013 0.82
72 The development of a clinical screening instrument for tumour predisposition syndromes in childhood cancer patients. Eur J Cancer 2013 0.82
73 Response assessment in pediatric rhabdomyosarcoma: can response evaluation criteria in solid tumors replace three-dimensional volume assessments? Radiology 2013 0.81
74 Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors. Clin J Am Soc Nephrol 2012 0.81
75 Preoperative chemotherapy for patients with Wilms tumor in Malawi is feasible and efficacious. Pediatr Blood Cancer 2009 0.81
76 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma. Cochrane Database Syst Rev 2015 0.80
77 Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity. Int J Cancer 2003 0.80
78 Synergistic interaction between cisplatin and gemcitabine in neuroblastoma cell lines and multicellular tumor spheroids. Cancer Lett 2011 0.80
79 Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis. Eur J Nucl Med Mol Imaging 2013 0.80
80 Prevention of anthracycline-induced cardiotoxicity in children: the evidence. Eur J Cancer 2007 0.79
81 Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids. Int J Oncol 2008 0.79
82 Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma. Clin Cancer Res 2011 0.79
83 Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. Cochrane Database Syst Rev 2014 0.78
84 Management of asymptomatic anthracycline-induced cardiac damage after treatment for childhood cancer: a postal survey among Dutch adult and pediatric cardiologists. J Pediatr Hematol Oncol 2005 0.78
85 The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma. Eur J Nucl Med Mol Imaging 2013 0.78
86 AMORE protocol in pediatric head and neck rhabdomyosarcoma: descriptive analysis of failure patterns. Head Neck 2005 0.78
87 Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. Cochrane Database Syst Rev 2009 0.78
88 Hepatic late adverse effects after antineoplastic treatment for childhood cancer. Cochrane Database Syst Rev 2011 0.78
89 Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children. Cochrane Database Syst Rev 2015 0.78
90 Validated assay for the simultaneous quantification of total vincristine and actinomycin-D concentrations in human EDTA plasma and of vincristine concentrations in human plasma ultrafiltrate by high-performance liquid chromatography coupled with tandem mass spectrometry. Rapid Commun Mass Spectrom 2009 0.77
91 Antagonistic effects of sequential administration of BL1521, a histone deacetylase inhibitor, and gemcitabine to neuroblastoma cells. Cancer Lett 2006 0.76
92 Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids. Free Radic Biol Med 2011 0.76
93 Response to "cancer care in the pediatric surgical patient: a paradigm to abolish volume-outcome disparities in surgery". Surgery 2009 0.75
94 The use of equivalent radiation dose in the evaluation of late effects after childhood cancer treatment. J Cancer Surviv 2014 0.75
95 High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programs. Pediatr Blood Cancer 2014 0.75
96 Determination of the deoxycytidine kinase activity in cell homogenates with a non-radiochemical assay using reversed-phase high performance liquid chromatography; Identification of a novel metabolite of 2-chlorodeoxyadenosine. J Chromatogr B Analyt Technol Biomed Life Sci 2004 0.75
97 Retinoic acid reduces the cytotoxicity of cyclopentenyl cytosine in neuroblastoma cells. FEBS Lett 2002 0.75
98 Neuroblastoma, maternal valproic acid use, in-vitro fertilization and family history of mosaic chromosome 22: coincidence or causal relationship? Clin Dysmorphol 2004 0.75
99 Local Resection and Brachytherapy for Primary Orbital Rhabdomyosarcoma: Outcome and Failure Pattern Analysis. Ophthal Plast Reconstr Surg 2016 0.75